Management of metastatic endometrial cancer: physicians' choices beyond the first line after approval of checkpoint inhibitors (vol 13, 1247291, 2023)
FRONTIERS IN ONCOLOGY(2024)
关键词
endometrial cancer,molecular classification,immune checkpoint inhibitors,dostarlimab,pembrolizumab plus lenvatinib
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要